Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
R P Byington
Dr R P Byington, Wake Forest University School of Medicine, Winston-Salem, NC, USA; firstname.lastname@example.org
In patients with type 2 diabetes and cardiovascular disease or risk factors, does intensive glucose control prevent cardiovascular events more than standard glucose control?
randomised controlled trial (Action to Control Cardiovascular Risk in Diabetes [ACCORD]).
blinded (outcome adjudication committee and …
Source of funding: National Institutes of Health; Centers for Disease Control and Prevention; General Clinical Research Centers.